Skip to main content

Table 1 Descriptive clinical, laboratory and radiological data of studied cases (n = 50)

From: Effect of zinc supplementation on growth Hormone Insulin growth factor axis in short Egyptian children with zinc deficiency

 

Mean ± SD

Range

Age (years)

6.5 ± 3.05

3.20-10.90

Height SDS

-3.12 ± 0.2

-2.15- -4.21

-GV after Zn (cm/3 months)

0.55 ± 0.1

0.1-2.23

-GV SDS after Zn

+1.01 ± 0.2

-0.5 - +2.11

- Weight SDS

-1.88 ± 0.62

-2.01- +0.55

- BMI SDS

-1.77 ± 0.41

-2.10- -0.78

- Serum Zn (μg/dl)

56.76 ± 7.90

37.52-93.11

-Peak GH after insulin stimulation (ng/ml)

10.65 ± 2.01

7.61-13.20

-Peak GH after clonidine stimulation (ng/ml)

11.14 ± 1.41

6.92-14.11

- IGF-1 (ng/ml)

96.72 ± 11.5

36.52-115.69

-IGF-1 SDS

-2.46 ± 0.11

-3.22- +0.55

- IGFBP-3 (ng/ml)

2436.12 ± 392

1195.45-3898.15

-BA (years)

3.7 ± 1.05

1.81-9.25

-BA SDS

-1.75 ± 1.14

-2.44 - +0.22

  1. Results are expressed as mean ± SD and range, Zn: zinc, SDS: Standard deviation score, GV: Growth velocity, BMI: Body mass index, GH: Growth hormone, IGF-1: Insulin like growth factor-1, IGFBP-3: Insulin like growth factor binding protein-3, BA: bone age.